- Home
- SNV vs LNTH Comparison
SNV vs LNTH Comparison
Compare SNV & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNV
- LNTH
- Stock Information
- Founded
- SNV 1888
- LNTH 1956
- Country
- SNV United States
- LNTH United States
- Employees
- SNV N/A
- LNTH N/A
- Industry
- SNV Major Banks
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- SNV Finance
- LNTH Health Care
- Exchange
- SNV Nasdaq
- LNTH Nasdaq
- Market Cap
- SNV 7.8B
- LNTH 6.3B
- IPO Year
- SNV N/A
- LNTH 2015
- Fundamental
- Price
- SNV $56.25
- LNTH $91.80
- Analyst Decision
- SNV Buy
- LNTH Strong Buy
- Analyst Count
- SNV 19
- LNTH 6
- Target Price
- SNV $58.47
- LNTH $132.67
- AVG Volume (30 Days)
- SNV 1.4M
- LNTH 722.1K
- Earning Date
- SNV 01-15-2025
- LNTH 02-20-2025
- Dividend Yield
- SNV 2.69%
- LNTH N/A
- EPS Growth
- SNV N/A
- LNTH 304.57
- EPS
- SNV 3.03
- LNTH 6.02
- Revenue
- SNV $1,852,496,000.00
- LNTH $1,496,799,000.00
- Revenue This Year
- SNV N/A
- LNTH $19.64
- Revenue Next Year
- SNV $6.71
- LNTH $5.16
- P/E Ratio
- SNV $18.17
- LNTH $15.25
- Revenue Growth
- SNV N/A
- LNTH 24.15
- 52 Week Low
- SNV $33.44
- LNTH $53.47
- 52 Week High
- SNV $59.92
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- SNV 59.28
- LNTH 47.44
- Support Level
- SNV $53.96
- LNTH $87.56
- Resistance Level
- SNV $57.22
- LNTH $95.70
- Average True Range (ATR)
- SNV 1.34
- LNTH 3.70
- MACD
- SNV 0.16
- LNTH -0.49
- Stochastic Oscillator
- SNV 74.34
- LNTH 31.57
About SNV Synovus Financial Corp.
Synovus Financial Corp provides commercial and consumer banking in addition to a full suite of specialized products & services such as private banking, treasury management, wealth management, mortgage services, premium finance, asset-based lending, structured lending, capital markets, & international banking to clients through the wholly-owned subsidiary bank, Synovus Bank, and other offices in Alabama, Florida, Georgia, South Carolina, and Tennessee. It has four segments Wholesale Banking, Community Banking, Consumer Banking, and Financial Management Services, out of which the majority is from the Wholesale banking segment.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.